A phase 1 study of the MDM2 inhibitor DS-3032b in patients (pts) with advanced solid tumors and lymphomas Meeting Abstract
| Authors: | Gounder, M. M.; Bauer, T. M.; Schwartz, G. K.; Masters, T.; Carvajal, R. D.; Song, S.; Kumar, P.; Gajee, R.; Zernovak, O.; Rosen, M. M.; Kochan, J. P.; Chen, S. Q.; Hyman, D. M.; Gokmen, S.; Meric-Bernstam, F.; LoRusso, P.; Somaiah, N.; Weise, A. M.; Hong, D. S. |
| Abstract Title: | A phase 1 study of the MDM2 inhibitor DS-3032b in patients (pts) with advanced solid tumors and lymphomas |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 134s |
| Language: | English |
| ACCESSION: | WOS:000404665403180 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.2581 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2581 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
